Best Momentum Stocks to Buy for January 21st

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 21st:

CareDx, Inc CDNA: This diagnostic solutions company for transplant patients and caregivers has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.5% over the last 60 days.

CareDx, Inc. Price and Consensus

CareDx, Inc. price-consensus-chart | CareDx, Inc. Quote

CareDx’s shares gained 13.6% over the last six months compared with the S&P 500’s advance of 7.7%. The company possesses a Momentum Score of A.

CareDx, Inc. Price

CareDx, Inc. price | CareDx, Inc. Quote

Anavex Life Sciences Corp. AVXL: This clinical stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days.

Anavex Life Sciences Corp. Price and Consensus

Anavex Life Sciences Corp. price-consensus-chart | Anavex Life Sciences Corp. Quote

Anavex’s shares gained 63.3% over the last three months compared with the S&P 500’s advance of 2.4%. The company possesses a Momentum Score of A.

Anavex Life Sciences Corp. Price

Anavex Life Sciences Corp. price | Anavex Life Sciences Corp. Quote

Alnylam Pharmaceuticals, Inc. ALNY: This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 20.4% over the last 60 days.

Alnylam Pharmaceuticals, Inc. Price and Consensus

Alnylam Pharmaceuticals, Inc. price-consensus-chart | Alnylam Pharmaceuticals, Inc. Quote

Alnylam’s shares gained 1.6% over the past month compared with the S&P 500’s advance of 0.4%. The company possesses a Momentum Score of A.

Alnylam Pharmaceuticals, Inc. Price

Alnylam Pharmaceuticals, Inc. price | Alnylam Pharmaceuticals, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.1% per year. So be sure to give these hand picked 7 your immediate attention.

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report